Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAUSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAY.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.25.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XADSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XABSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XALSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBWSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAY.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GY.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAY.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.10.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.99SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.343SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.409SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.310SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.362.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.162SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Y.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.86SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.154SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.137SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.446SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.398SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.3 (Theta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.38.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBHSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BL.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.9.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.221.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.38.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.79.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used